| Product Code: ETC8199448 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
Malta continues to see a significant influx of peptide drug conjugates imports in 2024, with top exporting countries including India, Israel, Ireland, Germany, and Belgium. The market remains highly concentrated, as indicated by the high Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 stands at a healthy 10.1%, with a notable growth rate of 29.61% from 2023 to 2024. This data suggests a strong and growing demand for peptide drug conjugates in Malta, with key players from various countries contributing to the market`s expansion.
| 1 Executive Summary | 
| 2 Introduction | 
| 2.1 Key Highlights of the Report | 
| 2.2 Report Description | 
| 2.3 Market Scope & Segmentation | 
| 2.4 Research Methodology | 
| 2.5 Assumptions | 
| 3 Malta Peptide Drug Conjugates Market Overview | 
| 3.1 Malta Country Macro Economic Indicators | 
| 3.2 Malta Peptide Drug Conjugates Market Revenues & Volume, 2021 & 2031F | 
| 3.3 Malta Peptide Drug Conjugates Market - Industry Life Cycle | 
| 3.4 Malta Peptide Drug Conjugates Market - Porter's Five Forces | 
| 3.5 Malta Peptide Drug Conjugates Market Revenues & Volume Share, By Product, 2021 & 2031F | 
| 3.6 Malta Peptide Drug Conjugates Market Revenues & Volume Share, By Type, 2021 & 2031F | 
| 4 Malta Peptide Drug Conjugates Market Dynamics | 
| 4.1 Impact Analysis | 
| 4.2 Market Drivers | 
| 4.3 Market Restraints | 
| 5 Malta Peptide Drug Conjugates Market Trends | 
| 6 Malta Peptide Drug Conjugates Market, By Types | 
| 6.1 Malta Peptide Drug Conjugates Market, By Product | 
| 6.1.1 Overview and Analysis | 
| 6.1.2 Malta Peptide Drug Conjugates Market Revenues & Volume, By Product, 2021- 2031F | 
| 6.1.3 Malta Peptide Drug Conjugates Market Revenues & Volume, By OctreoScan, 2021- 2031F | 
| 6.1.4 Malta Peptide Drug Conjugates Market Revenues & Volume, By Lutathera, 2021- 2031F | 
| 6.1.5 Malta Peptide Drug Conjugates Market Revenues & Volume, By Pepaxto, 2021- 2031F | 
| 6.1.6 Malta Peptide Drug Conjugates Market Revenues & Volume, By ANG1005, 2021- 2031F | 
| 6.1.7 Malta Peptide Drug Conjugates Market Revenues & Volume, By BT1718, 2021- 2031F | 
| 6.2 Malta Peptide Drug Conjugates Market, By Type | 
| 6.2.1 Overview and Analysis | 
| 6.2.2 Malta Peptide Drug Conjugates Market Revenues & Volume, By Therapeutic, 2021- 2031F | 
| 6.2.3 Malta Peptide Drug Conjugates Market Revenues & Volume, By Diagnostic, 2021- 2031F | 
| 7 Malta Peptide Drug Conjugates Market Import-Export Trade Statistics | 
| 7.1 Malta Peptide Drug Conjugates Market Export to Major Countries | 
| 7.2 Malta Peptide Drug Conjugates Market Imports from Major Countries | 
| 8 Malta Peptide Drug Conjugates Market Key Performance Indicators | 
| 9 Malta Peptide Drug Conjugates Market - Opportunity Assessment | 
| 9.1 Malta Peptide Drug Conjugates Market Opportunity Assessment, By Product, 2021 & 2031F | 
| 9.2 Malta Peptide Drug Conjugates Market Opportunity Assessment, By Type, 2021 & 2031F | 
| 10 Malta Peptide Drug Conjugates Market - Competitive Landscape | 
| 10.1 Malta Peptide Drug Conjugates Market Revenue Share, By Companies, 2024 | 
| 10.2 Malta Peptide Drug Conjugates Market Competitive Benchmarking, By Operating and Technical Parameters | 
| 11 Company Profiles | 
| 12 Recommendations | 
| 13 Disclaimer |